Two Sigma Advisers’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-650
| Closed | -$3K | – | 2759 |
|
|
2022
Q3 | $3K | Buy |
+650
| New | +$3K | ﹤0.01% | 2514 |
|
|
2022
Q2 | – | Sell |
-7,205
| Closed | -$86K | – | 2955 |
|
|
2022
Q1 | $86K | Sell |
7,205
-335
| -4% | -$4K | ﹤0.01% | 2527 |
|
|
2021
Q4 | $148K | Buy |
7,540
+6,140
| +439% | +$121K | ﹤0.01% | 2361 |
|
|
2021
Q3 | $36K | Sell |
1,400
-75,725
| -98% | -$1.95M | ﹤0.01% | 2389 |
|
|
2021
Q2 | $1.7M | Buy |
77,125
+18,140
| +31% | +$399K | ﹤0.01% | 1374 |
|
|
2021
Q1 | $1.38M | Buy |
58,985
+55,430
| +1,559% | +$1.3M | ﹤0.01% | 1463 |
|
|
2020
Q4 | $61K | Sell |
3,555
-1,105
| -24% | -$19K | ﹤0.01% | 2306 |
|
|
2020
Q3 | $76K | Buy |
+4,660
| New | +$76K | ﹤0.01% | 2294 |
|
|
2018
Q4 | – | Sell |
-500
| Closed | -$68K | – | 2500 |
|
|
2018
Q3 | $68K | Buy |
+500
| New | +$68K | ﹤0.01% | 2167 |
|